Trial Profile
Alteplase for Blood Flow Restoration in Hemodialysis Catheters: A Randomized Prospective Clinical Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Catheter thrombosis
- Focus Therapeutic Use
- 17 Dec 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 17 Dec 2008 Actual initiation date changed from Sep 2002 to Sep 2004 as reported by ClinicalTrials.gov.